← Eichor
Study identifier: NCT07244510 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

Condition: Hidradenitis Suppurativa (HS)  ·  Sponsor: Sinocelltech Ltd.

PhasePhase 2
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidradenitis Suppurativa

This description comes directly from the study's public registry record.

Talk to the study team

Miaomiao Zhang, PhD  ·  17628293460  ·  miaomiao_zhang@sinocelltech.com

Müge Güler Özden, MD  ·  905324068600  ·  mgulerozden@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ondokuz Mayis University Medical FacultySamsun, Turkey, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07244510